AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+8.05%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.09B
AUM Growth
+$2.09B
Cap. Flow
+$237M
Cap. Flow %
11.31%
Top 10 Hldgs %
57.89%
Holding
113
New
16
Increased
20
Reduced
14
Closed
6

Top Buys

1
NVDA icon
NVIDIA
NVDA
$75.4M
2
GOSS icon
Gossamer Bio
GOSS
$36M
3
XLRN
Acceleron Pharma Inc.
XLRN
$27.9M
4
EPZM
Epizyme, Inc
EPZM
$21.7M
5
BPMC
Blueprint Medicines
BPMC
$20M

Top Sells

1
ARRY
Array Biopharma Inc
ARRY
$12.2M
2
BLUE
bluebird bio
BLUE
$11.8M
3
CMTA
Clementia Pharmaceuticals Inc.
CMTA
$10M
4
ANAB icon
AnaptysBio
ANAB
$9.57M
5
ARGX icon
argenx
ARGX
$8.74M

Sector Composition

1 Healthcare 74.84%
2 Consumer Discretionary 19.28%
3 Technology 3.6%
4 Real Estate 0.42%
5 Communication Services 0.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ACET icon
76
Adicet Bio
ACET
$59.9M
$2.73M 0.11% 400,000 – –
DTIL icon
77
Precision BioSciences
DTIL
$57.8M
$2.69M 0.11% +150,000 New +$2.69M
GRTS
78
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$2.66M 0.11% 200,000 – –
TECX
79
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$2.21M 0.09% 100,000 – –
CTMX icon
80
CytomX Therapeutics
CTMX
$336M
$2.15M 0.09% 200,000 +50,000 +33% +$538K
LRMR icon
81
Larimar Therapeutics
LRMR
$310M
$1.92M 0.08% 700,000 – –
ARAV
82
DELISTED
Aravive, Inc. Common Stock
ARAV
$1.8M 0.07% +256,269 New +$1.8M
WHWK
83
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
$1.4M 0.06% 1,558,400 – –
VRDN icon
84
Viridian Therapeutics
VRDN
$1.5B
$1.4M 0.06% 500,000 – –
TIGR
85
UP Fintech Holding
TIGR
$2.21B
$1.29M 0.05% +100,000 New +$1.29M
IRWD icon
86
Ironwood Pharmaceuticals
IRWD
$214M
$1.25M 0.05% 110,532 – –
CMRX
87
DELISTED
Chimerix, Inc.
CMRX
$1.05M 0.04% 500,000 -500,000 -50% -$1.05M
NVLN
88
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$315K 0.01% 256,400 – –
TRIL
89
DELISTED
Trillium Therapeutics Inc.
TRIL
$99K ﹤0.01% 150,000 – –
AAL icon
90
American Airlines Group
AAL
$8.82B
– – 0 – –
YMAB icon
91
Y-mAbs Therapeutics
YMAB
$388M
– – -50,000 Closed -$1.02M
QTTB icon
92
Q32 Bio
QTTB
$20.9M
– – -100,000 Closed -$2.24M
MRNS
93
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– – -500,000 Closed -$1.44M
AMRN
94
Amarin Corp
AMRN
$311M
– – 0 – –
ANAB icon
95
AnaptysBio
ANAB
$569M
– – -150,000 Closed -$9.57M
BAC icon
96
Bank of America
BAC
$376B
– – 0 – –
BMRN icon
97
BioMarin Pharmaceuticals
BMRN
$11.2B
– – 0 – –
BMY icon
98
Bristol-Myers Squibb
BMY
$96B
– – 0 – –
FCX icon
99
Freeport-McMoran
FCX
$63.7B
– – 0 – –
GM icon
100
General Motors
GM
$55.8B
– – 0 – –
1 2 3
4
5